Literature DB >> 7845035

Scintigraphy of the whole gut: clinical evaluation of transit disorders.

F Charles1, M Camilleri, S F Phillips, G M Thomforde, L A Forstrom.   

Abstract

OBJECTIVE: To describe an initial clinical experience with a noninvasive scintigraphic technique for assessing gastrointestinal motility.
DESIGN: We studied gastric, small bowel, and colonic transit in 109 unselected patients encountered between June and December 1992 at the Mayo Clinic.
MATERIAL AND METHODS: The study patients were categorized on the basis of major complaint (constipation in 46, upper gastrointestinal symptoms in 45, and diarrhea in 18) and presence or absence of an underlying organic disease. Radioscintigraphy was used to analyze various regions of the gastrointestinal tract; scans were obtained at 2, 4, 6, and 24 hours after ingestion of a radiolabeled test meal.
RESULTS: Overall, patients with a main complaint of constipation usually had slow or normal gastric, small bowel, and colonic transit, whereas those with diarrhea as the major symptom usually had normal or fast results of these studies. In the 65 patients with no underlying organic disease, inconsistent patterns of gastric emptying and small bowel and colonic transit were noted.
CONCLUSION: Our results suggest that this 24-hour scintigraphic test may be clinically useful in screening for dysmotility syndromes in patients with nausea, vomiting, diarrhea, or constipation.

Entities:  

Mesh:

Year:  1995        PMID: 7845035     DOI: 10.4065/70.2.113

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  22 in total

Review 1.  Chronic vomiting in children: new insights into diagnosis.

Authors:  S Khan; C Di Lorenzo
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Chronic Intestinal Pseudo-obstruction.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

Review 3.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

Review 4.  Measurement of gastrointestinal transit.

Authors:  Henry C Lin; Charlene Prather; Robert S Fisher; James H Meyer; Robert W Summers; Mark Pimentel; Richard W McCallum; Louis M A Akkermans; Vera Loening-Baucke
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

5.  Postprandial skeletal muscle metabolism following a high-fat diet in sedentary and endurance-trained males.

Authors:  Mary Elizabeth Baugh; Suzanne M Bowser; Ryan P McMillan; Brenda M Davy; Lauren A Essenmacher; Andrew P Neilson; Matthew W Hulver; Kevin P Davy
Journal:  J Appl Physiol (1985)       Date:  2020-03-12

Review 6.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 7.  Approach to patients with refractory constipation.

Authors:  S A Wofford; G N Verne
Journal:  Curr Gastroenterol Rep       Date:  2000-10

8.  Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument.

Authors:  Michael Camilleri
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-20       Impact factor: 11.382

9.  Slow-transit constipation with concurrent upper gastrointestinal dysmotility and its response to transcutaneous electrical stimulation.

Authors:  Yee Ian Yik; Melanie C C Clarke; Anthony G Catto-Smith; Val J Robertson; Jonathan R Sutcliffe; Janet W Chase; Susan Gibb; Timothy M Cain; David J Cook; Coral F Tudball; John M Hutson; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2011-03-04       Impact factor: 1.827

Review 10.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.